Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Matthew Britz, Francesco Caiazza, Aditi Hazra, Neetu Singh


Retrogenix has tapped Matthew Britz to be its North American business development director. Britz will operate out of the UK firm's newly established US office in Cambridge, Mass. He previously served as director of business development at Evory Therapeutics and earlier in his career held scientific and managerial positions at Pfizer, Merck, and Acambis.

Affymetrix has announced the three recipients of its 2014 Tumor Profiling Grant. The grants support translational cancer research. Recipients receive tools to discover and validate at least two different analytes – DNA, RNA, or protein – from 30 tumor samples.

The new recipients and their project titles are:

  • Francesco Caiazza from University College Dublin, for "Discovery and validation of biomarkers of resistance to Cetuximab in metastatic colorectal cancer."
  • Aditi Hazra from Brigham and Women's Hospital for "Discovery and validation of genomic and transcriptomic biomarkers associated with rapid onset of inflammatory breast cancer."
  • Neetu Singh of King George's Medical University, India, for "Genomics and transcriptomics of chronic myeloid leukemia in North Indians."